Investment Review №330. Profit favors the bold

23.09.2025 — 6656

• Micron Technology, Inc. (MU) released outstanding results for Q4 FY 2025 and provided record-breaking forecasts for Q1 FY 2026, surpassing all market expectations.

 

26.09.2025 — ▼6643

• The PCE deflator data once again revealed a moderate impact of tariffs, with the overall index increasing by 0.26% m/m and the core index, excluding food and fuel prices, rising by 0.23% m/m.
• Personal Income and Spending data for August exceeded consensus forecasts. Personal Income grew by 0.37% m/m, versus analysts’ median forecast of 0.3% m/m, while Spending rose by 0.62% m/m, compared to a forecast of 0.5% m/m.

30.09.2025 — ▲6688

• NIKE, Inc. reported sales growth for the first time after five consecutive disappointing quarters, with Q1 FY26 revenue increasing by 1.1% to $11.72 billion, notably outperforming the consensus forecast of $10.97 billion.
• Pfizer (PFE) reached an agreement with the U.S. Government to reduce pharmaceutical prices. Pfizer has agreed to limit prices for primary care drugs and certain specialty care products.

01.10.2025 — ▲6711

• The federal government shut down after Congress failed to reach an agreement on extending funding for the new fiscal year, causing a delay in the release of macroeconomic data.